Short Interest in Poxel S.A. (OTCMKTS:PXXLF) Grows By 9,300.0%

Poxel S.A. (OTCMKTS:PXXLF) was the target of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 9,400 shares, a growth of 9,300.0% from the January 31st total of 100 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Poxel Stock Performance

Poxel stock remained flat at $0.25 during mid-day trading on Thursday. The stock’s 50 day moving average is $0.25 and its 200-day moving average is $0.49. Poxel has a 12-month low of $0.25 and a 12-month high of $0.25.

Poxel Company Profile

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.